Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-446,874
Closed -$37.5M 20
2025
Q3
$37.5M Buy
+446,874
New +$36.8M 8.62% 3
2024
Q2
Sell
-119,200
Closed -$15.7M 33
2024
Q1
$15.7M Buy
+119,200
New +$14.7M 5.45% 7
2023
Q2
Sell
-114,242
Closed -$12.2M 73
2023
Q1
$12.2M Sell
114,242
-12,670
-10% -$1.37M 3.7% 11
2022
Q4
$14.1M Buy
+126,912
New +$13M 5.7% 5
2021
Q4
Sell
-181,765
Closed -$13.7M 49
2021
Q3
$13.7M Buy
+181,765
New +$13.8M 5.43% 7
2021
Q1
Sell
-3,805
Closed -$297K 64
2020
Q4
$297K Buy
+3,805
New +$291K 0.11% 48

Other funds holding MRK

Tri Locum Partners's MRK Position: Q4 2025 in Review

Tri Locum Partners sold out of Merck (MRK) in Q4 2025, closing a stake of 446,874 shares — an estimated $37.5M sold.

Tri Locum Partners first reported a position in MRK in Q4 2020 and held it in 6 quarters. The position peaked at $37.5M in Q3 2025. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Tri Locum Partners reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Tri Locum Partners sold 446,874 Merck shares in Q4 2025, an estimated $37.5M.
  • Tri Locum Partners first reported a position in Merck in Q4 2020 and held it in 6 quarters.
  • Tri Locum Partners's Merck position peaked at $37.5M in Q3 2025.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Tri Locum Partners's 13F filing for Q4 2025, filed 17 Feb 2026.